Quantinno Capital Management LP Has $10.75 Million Holdings in Koninklijke Philips N.V. $PHG

Quantinno Capital Management LP lifted its holdings in Koninklijke Philips N.V. (NYSE:PHG) by 31.7% during the first quarter, HoldingsChannel.com reports. The firm owned 392,219 shares of the technology company’s stock after purchasing an additional 94,413 shares during the period. Quantinno Capital Management LP’s holdings in Koninklijke Philips were worth $10,747,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in PHG. GC Wealth Management RIA LLC increased its stake in Koninklijke Philips by 34.2% in the 1st quarter. GC Wealth Management RIA LLC now owns 47,015 shares of the technology company’s stock valued at $1,288,000 after buying an additional 11,977 shares during the last quarter. Compound Planning Inc. acquired a new position in shares of Koninklijke Philips during the 1st quarter worth about $247,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of Koninklijke Philips during the 1st quarter worth about $1,478,000. Cloverfields Capital Group LP grew its holdings in shares of Koninklijke Philips by 1.2% in the 1st quarter. Cloverfields Capital Group LP now owns 70,940 shares of the technology company’s stock valued at $1,944,000 after acquiring an additional 868 shares in the last quarter. Finally, Sei Investments Co. grew its holdings in shares of Koninklijke Philips by 4.7% in the 1st quarter. Sei Investments Co. now owns 486,941 shares of the technology company’s stock valued at $13,343,000 after acquiring an additional 22,039 shares in the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

Shares of PHG opened at $26.21 on Tuesday. The company has a market cap of $25.77 billion, a PE ratio of 19.32, a price-to-earnings-growth ratio of 10.91 and a beta of 0.76. The firm has a 50-day moving average of $26.63 and a 200-day moving average of $27.90. Koninklijke Philips N.V. has a one year low of $23.85 and a one year high of $33.44. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.26 and a quick ratio of 0.82.

Koninklijke Philips (NYSE:PHG) last issued its earnings results on Wednesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.03. Koninklijke Philips had a net margin of 6.30% and a return on equity of 14.38%. The company had revenue of $4.52 billion for the quarter, compared to analysts’ expectations of $4.49 billion. As a group, equities analysts forecast that Koninklijke Philips N.V. will post 1.75 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on PHG shares. Wall Street Zen upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings lowered Koninklijke Philips from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday, July 21st. UBS Group reiterated a “neutral” rating on shares of Koninklijke Philips in a research note on Monday. Finally, Zacks Research downgraded Koninklijke Philips from a “hold” rating to a “strong sell” rating in a report on Wednesday, July 15th. Four analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.